Newsletter - October 24, 2019
Healthcare Apps Pose Several Safety Concerns to Users
Healthcare management apps pose several risks to consumers using them including giving incomplete or incorrect information, providing non-validated instructions for managing a given health condition, failure to respond to health danger, and faulty alarms. This is based on a review of 74 independent clinical studies conducted in the last two years...Read More
FDA Warns another CBD Manufacturer but does it Address the Broader Issue
This week FDA and FTC jointly issued a Warning Letter to another CBD manufacturer for selling CBD as an unapproved drug for pediatric diseases among other claims, and for selling CBD as a dietary supplement. This warning letter is similar to other warning letters issued by FDA in recent years to manufacturers of CBD containing products...Read More
Healthcare Apps Pose Several Safety Concerns to Users
Healthcare management apps pose several risks to consumers using them including giving incomplete or incorrect information, providing non-validated instructions for managing a given health condition, failure to respond to health danger, and faulty alarms. This is based on a review of 74 independent clinical studies conducted in the last two years...Read More
FDA Warns another CBD Manufacturer but does it Address the Broader Issue
This week FDA and FTC jointly issued a Warning Letter to another CBD manufacturer for selling CBD as an unapproved drug for pediatric diseases among other claims, and for selling CBD as a dietary supplement. This warning letter is similar to other warning letters issued by FDA in recent years to manufacturers of CBD containing products...Read More
